Itamar Medical Ltd. (ITMR.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
114.70-3.00 (-2.55%)
At close: 10:24 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close117.70
Bid114.30 x 534600
Ask114.90 x 285000
Day's Range114.30 - 118.30
52wk Range1.04 - 118.30
1y Target EstN/A
Market Cap301.57M
P/E Ratio (ttm)-2,085.45
Avg Vol (3m)387,897
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Itamar Medical Ltd. :ITMR-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 17, 2016
    Capital Cube2 months ago

    Itamar Medical Ltd. :ITMR-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 17, 2016

    Categories: Yahoo Finance Get free summary analysis Itamar Medical Ltd. reports financial results for the quarter ended June 30, 2016. Highlights Summary numbers: Revenues of ILS 17.06 million, Net Earnings of ILS -22.15 million. Gross margins widened from 70.18% to 74.76% compared to the same period last year, operating (EBITDA) margins now -45.41% from -22.94%. Change in operating ... Read more (Read more...)

  • PR Newswire3 months ago

    FDA Clears Expanded Indication for Itamar Medical's WatchPAT™ Sleep Apnea Diagnostic Device for Adolescents

    Itamar Medical (ITMR.TA), which develops and markets non-invasive diagnostic medical devices for sleep-related breathing disorders, received FDA clearance to expand the medical indication of WatchPAT for sleep apnea diagnosis. Under this approval, the use of WatchPAT in the USA is permitted from the age of twelve, expanding the previous indication for ages seventeen and older. WatchPAT is a Home Sleep Test (HST) diagnostic device for sleep apnea.

  • Reuters2 years ago

    Itamar Medical sees growth in sleep disorder, heart markets

    Israel's Itamar Medical expects to end three years of sluggish growth after signing three new sales agreements in the United States and Japan, chief executive Gilad Glick said. The company, which makes devices that test for sleep and cardiovascular problems with a simple fingertip sensor, is also benefiting from a growing awareness of sleep disorders, which is a $3.5 billion market in the United States, Glick said. The larger cardiovascular system must be used in a clinic and in January it received for the first time a reimbursement code for U.S.